Central Serous Chorioretinopathy Clinical Trial
Official title:
The Changes of Retinal and Choroidal Capillaries After Half-dose Photodynamic Therapy Measured by Angio- OCT in Eyes With Central Serous Chorioretinopathy
To determine changes in retinal and choroidal capillaries with optical coherence tomographic angiography (OCTA) after half-dose photodynamic therapy (hd-PDT) in eyes with central serous chorioretinopathy (CSC).
PDT was hypothesized to have a primary effect on the choroidal capillaries, and a number of
studies have reported choriocapillary damage and choroidal vascular remodeling after PDT.
More recently, although OCTA related CSC research has been conducted, no quantitative report
has thoroughly investigated the microstructural changes in the superficial, deep retinal and
choroidal capillaries after hd-PDT. The purpose of the present study is to determine the
changes in the retinal and choroidal capillaries quantitatively with OCTA after hd-PDT in
eyes with CSC.
This is a prospective observational study of patients undergoing hd-PDT for CSC with active
leakage in retinal pigment epithelium (RPE) and followed for 3 months. Fundus fluorescein
angiography (FFA) and indocyanine green angiography (ICGA) were performed at baseline; best
corrected visual acuity (BCVA), fundus photography, optical coherence tomography angiography
(OCTA) with the split-spectrum amplitude-decorrelation angiography algorithm (XR Optovue,
Fremont, CA, USA) and spectral domain OCT (SD-OCT) were performed at baseline and each
follow-up visit after hd-PDT.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03497000 -
Effects of OCTA-guided PDT in Acute CSC
|
N/A | |
| Not yet recruiting |
NCT02215330 -
A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
|
Phase 2/Phase 3 | |
| Completed |
NCT01990677 -
Eplerenone for the Treatment of Central Serous Chorioretinopathy
|
N/A | |
| Completed |
NCT01971190 -
Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
|
Phase 2 | |
| Active, not recruiting |
NCT01710332 -
The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
|
Phase 2 | |
| Active, not recruiting |
NCT00403884 -
Selective RPE Laser Treatment (SRT) for Various Macular Diseases
|
N/A | |
| Recruiting |
NCT05570591 -
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
|
N/A | |
| Recruiting |
NCT05589974 -
Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
|
||
| Completed |
NCT05104138 -
Eplerenone Versus PDT: Comparative Study by OCTA
|
||
| Terminated |
NCT01982383 -
Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy
|
N/A | |
| Completed |
NCT01880788 -
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
|
N/A | |
| Completed |
NCT01327170 -
Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy
|
N/A | |
| Completed |
NCT01019668 -
Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
|
N/A | |
| Recruiting |
NCT06346405 -
Central Serous Chorioretinopathy and Micropulse Laser Treatment
|
||
| Recruiting |
NCT02141308 -
OCT in Rare Chorioretinal Diseases
|
||
| Completed |
NCT01822561 -
Eplerenone for Central Serous Chorioretinopathy
|
Phase 2 | |
| Completed |
NCT00802906 -
Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
|
N/A | |
| Withdrawn |
NCT05679180 -
Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE
|
N/A | |
| Completed |
NCT05686421 -
Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations
|
N/A | |
| Completed |
NCT03758963 -
Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy
|
N/A |